RATIONALE: People with allergic rhinitis (AR) experience bothersome nasal symptoms and exacerbations (usually defined as a rapid, clinically significant symptom progression) of their symptoms. A study was conducted to evaluate the effect of mometasone furoate nasal spray (MFNS) on Chinese patients experiencing exacerbations of AR.
第一作者机构：[1]Beijing Tong Ren Hosp, Beijing, Peoples R China
推荐引用方式(GB/T 7714)：
Huang Z..Mometasone furoate nasal spray significantly improves exacerbations of allergic rhinitis over 28 days of treatment[J].JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY.2008,121(2):S56-S56.doi:10.1016/j.jaci.2007.12.226.
APA：
Huang, Z..(2008).Mometasone furoate nasal spray significantly improves exacerbations of allergic rhinitis over 28 days of treatment.JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY,121,(2)
MLA：
Huang, Z.."Mometasone furoate nasal spray significantly improves exacerbations of allergic rhinitis over 28 days of treatment".JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY 121..2(2008):S56-S56
医学